Ahn YM, , Gajdusek C, , London S, , Moon CT, , Oh CW, & Mayberg MR: Sustained arterial narrowing after prolonged exposure to perivascular endothelin. Neurosurgery 50:843–849, 2002 Ahn YM, Gajdusek C, London S, Moon CT, Oh CW, Mayberg MR: Sustained arterial narrowing after prolonged exposure to perivascular endothelin. Neurosurgery 50:843–849, 2002
Asano T, , Ikegaki I, , Satoh S, , Suzuki Y, , Shibuya M, & Sugita K, et al: Endothelin: a potential modulator of cerebral vasospasm. Eur J Pharmacol 190:365–372, 1990 Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Sugita K, et al: Endothelin: a potential modulator of cerebral vasospasm. Eur J Pharmacol 190:365–372, 1990
Asano T, , Ikegaki I, , Suzuki Y, , Satoh S, & Shibuya M: Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun 159:1345–1351, 1989 Asano T, Ikegaki I, Suzuki Y, Satoh S, Shibuya M: Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun 159:1345–1351, 1989
Chow M, , Dumont AS, & Kassell NF: Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 51:1333–1342, 2002 Chow M, Dumont AS, Kassell NF: Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 51:1333–1342, 2002
Drake CG: Concluding remarks, in Sano K, , Takakura K, & Kassell NF et al (eds): International Conference on Cerebral Vasospasm: Tokyo 1990, Proceeding of the 4th International Conference in Tokyo. Tokyo: Univ. of Tokyo Press, 1990, pp 527–531 Drake CG: Concluding remarks, in Sano K, Takakura K, Kassell NF et al (eds): International Conference on Cerebral Vasospasm: Tokyo 1990, Proceeding of the 4th International Conference in Tokyo. Tokyo: Univ. of Tokyo Press, 1990, pp 527–531
Dumont AS, , Dumont RJ, , Chow MM, , Lin CL, , Calisaneller T, & Ley KF, et al: Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53:123–135, 2003 Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al: Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53:123–135, 2003
Fassbender K, , Hodapp B, , Rossol S, , Bertsch T, , Schmeck J, & Schutt S, et al: Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 31:2971–2975, 2000 Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, et al: Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 31:2971–2975, 2000
Hansen-Schwartz J: Receptor changes in cerebral arteries after subarachnoid haemorrhage. Acta Neurol Scand 109:33–44, 2004 Hansen-Schwartz J: Receptor changes in cerebral arteries after subarachnoid haemorrhage. Acta Neurol Scand 109:33–44, 2004
Hino A, , Tokuyama Y, , Kobayashi M, , Yano M, , Weir B, & Takeda J, et al: Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 16:688–697, 1996 Hino A, Tokuyama Y, Kobayashi M, Yano M, Weir B, Takeda J, et al: Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 16:688–697, 1996
Juvela S, , Siironen J, , Varis J, , Poussa K, & Porras M: Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage. J Neurosurg 102:194–201, 2005 Juvela S, Siironen J, Varis J, Poussa K, Porras M: Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage. J Neurosurg 102:194–201, 2005
Kawanabe Y, , Masaki T, & Hashimoto N: Involvement of epidermal growth factor receptor—protein tyrosine kinase transactivation in endothelin-1—induced vascular contraction. J Neurosurg 100:1066–1071, 2004 Kawanabe Y, Masaki T, Hashimoto N: Involvement of epidermal growth factor receptor—protein tyrosine kinase transactivation in endothelin-1—induced vascular contraction. J Neurosurg 100:1066–1071, 2004
Kirchengast M, & Luz M: Endothelin receptor antagonists: clinical realities and future directions. J Cardiovasc Pharmacol 45:182–191, 2005 Kirchengast M, Luz M: Endothelin receptor antagonists: clinical realities and future directions. J Cardiovasc Pharmacol 45:182–191, 2005
Miyauchi T, & Masaki T: Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61:391–415, 1999 Miyauchi T, Masaki T: Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61:391–415, 1999
Ono K, & Matsumori A: Endothelin antagonism with bosentan: current status and future perspectives. Cardiovasc Drug Rev 20:1–18, 2002 Ono K, Matsumori A: Endothelin antagonism with bosentan: current status and future perspectives. Cardiovasc Drug Rev 20:1–18, 2002
Purdy PD, , Replogle RE, , Pride GL Jr, , Adams C, , Miller S, & Samson D: Percutaneous intraspinal navigation: feasibility study of a new and minimally invasive approach to the spinal cord and brain in cadavers. AJNR 24:361–365, 2003 Purdy PD, Replogle RE, Pride GL Jr, Adams C, Miller S, Samson D: Percutaneous intraspinal navigation: feasibility study of a new and minimally invasive approach to the spinal cord and brain in cadavers. AJNR 24:361–365, 2003
Rappard G, , Metzger GJ, , Fleckenstein JL, , Babcock EE, , Weatherall PT, & Replogle RE, et al: MR-guided catheter navigation of the intracranial subarachnoid space. AJNR 24:626–629, 2003 Rappard G, Metzger GJ, Fleckenstein JL, Babcock EE, Weatherall PT, Replogle RE, et al: MR-guided catheter navigation of the intracranial subarachnoid space. AJNR 24:626–629, 2003
Roux S, , Breu V, , Ertel SI, & Clozel M: Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 77:364–376, 1999 Roux S, Breu V, Ertel SI, Clozel M: Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 77:364–376, 1999
Shaw MDM, , Vermeulen M, , Murray GD, , Pickard JD, , Bell BA, & Teasdale GM: Efficacy and safety of the endothelinA/B, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 93:992–997, 2000 Shaw MDM, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM: Efficacy and safety of the endothelinA/B, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 93:992–997, 2000
Vajkoczy P, , Meyer B, , Weidauer S, , Raabe A, , Thome C, & Ringel F, et al: Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter, Phase IIa study. J Neurosurg 103:9–17, 2005 Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, et al: Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter, Phase IIa study. J Neurosurg 103:9–17, 2005
Yanagisawa M, , Kurihara H, , Kimura S, , Tomobe Y, , Kobayashi M, & Mitsui Y, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415, 1988 Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415, 1988
Zimmermann M: Endothelin in cerebral vasospasm. Clinical and experimental results. J Neurosurg Sci 41:139–151, 1997 Zimmermann M: Endothelin in cerebral vasospasm. Clinical and experimental results. J Neurosurg Sci 41:139–151, 1997
Zimmermann M, & Seifert V: Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 43:863–876, 1998 Zimmermann M, Seifert V: Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 43:863–876, 1998
Zuccarello M: Endothelin: the “prime suspect” in cerebral vasospasm. Acta Neurochir Suppl 77:61–65, 2001 Zuccarello M: Endothelin: the “prime suspect” in cerebral vasospasm. Acta Neurochir Suppl 77:61–65, 2001
Zuccarello M, , Boccaletti R, , Romano A, & Rapoport RM: Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 29:1924–1929, 1998 Zuccarello M, Boccaletti R, Romano A, Rapoport RM: Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 29:1924–1929, 1998
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 737 | 53 | 10 |
| Full Text Views | 107 | 5 | 2 |
| PDF Downloads | 141 | 5 | 2 |
| EPUB Downloads | 0 | 0 | 0 |